One Sentence Summary: Our data provide a novel cAMP-dependent mechanism of seizure initiation in focal cortical dysplasia and tuberous sclerosis complex due to the unexpected ectopic expression of HCN4 channels only in diseased neurons. HCN4 channels are thus promising candidates for gene therapy to treat epilepsy generated by mTOR-driven focal malformations.
Introduction
Disorders caused by mutations in the mTOR pathway genes lead to mTOR hyperactivity, brain malformations, and life-long epilepsy in the majority of patients (1-3). Among this group of disorders, FCD and TSC account for the largest population of children and young adults that undergo brain surgery to treat intractable epilepsy (4) (5) (6) . Nearly two-thirds of these patients are refractory to treatment with antiepileptic drugs and experience life-long seizures, leading to a spectrum of neurocognitive and psychological disabilities (1). Upon failure of conventional antiepileptic drugs, surgical resection of the seizure foci or pharmacological inhibition of mTOR signaling in the case of TSC are the only available treatments for mTOR-dependent focal epilepsy, but neither option is fully effective (7) (8) (9) . Despite the identification of the molecular pathways dysregulated in TSC and FCDII and the pathological characteristics associated with seizures (4, (9) (10) (11) , the mechanism of epileptogenesis remains unknown, although several hypotheses of epileptogenicity have been proposed. These include abnormal reorganization of the circuitry within and surrounding FCMs and abnormal electrophysiological properties of FCM neurons (5, (12) (13) (14) (15) . However, none of these mechanisms has been tested. In addition, the exact site and the cell types responsible for epileptogenic activity in humans remain controversial as some studies have recorded epileptic discharges both inside and outside of FCMs whereas other studies have found FCMs to be electrically silent (14, 15) . The lack of consensus on the site of seizure generation further reflects our poor understanding of the epileptogenic mechanisms, which has hampered the identification of novel therapeutic targets and effective treatment options. Using a mouse model of TSC and FCDII (16) , we show that silencing FCM neurons prevents the occurrence of seizures, suggesting that FCM neurons are responsible for seizure activity. To identify how FCM neurons drive seizures, we obtained patch clamp recordings in FCM neurons and unexpectedly identified the abnormal expression of HCN4, which is not present in normal pyramidal neurons. While FCM neurons were depolarized and hence closer to the threshold for action potential generation, they required significantly more current injection than in controls to reach that threshold due to the cells' increased size and intrinsic conductance. Consistent with the fact that HCN4 channels are the most cAMP sensitive of all HCN channels (17) (18) (19) , increasing intracellular cAMP induced repetitive firing of FCM neurons and provides a novel mechanism of firing and seizure induction compared to the traditional excitatory input-induced firing mechanism.
Importantly, HCN4 was also found in dysmorphic cortical neurons from TSC and FCDII patients who underwent surgery for epilepsy treatment. Finally, using a genetic approach to block HCN4 activity in FCM neurons prevented seizures. Collectively, our findings identify a novel mechanism of seizures in mTOR-dependent FCM that provide the first gene therapy treatment option to prevent seizure initiation in patients with TSC and FCDII.
Results

Silencing FCM neurons decreases seizure activity
To investigate the mechanisms of seizure generation in FCM, we used a mouse model that recapitulates the focal nature of the cortical malformation and the cellular mosaicism of human FCDII and TSC brains (16, 20) . To generate this model, we used in utero electroporation (IUE) to induce mTOR hyperactivity in neurons in a limited cortical area at embryonic day (E) 15 ( Fig. 1A ) (16, (20) (21) (22) (23) (24) . To increase mTOR activity, we expressed a constitutively active mutant Rheb (Rheb CA ), the canonical mTOR activator (21, 23, (25) (26) (27) (Fig. 1B) . A fluorescent protein (GFP or tdTomato) was co-expressed to label neurons. These mice developed a singular FCM in the medial prefrontal cortex (Fig. 1C ) that displayed a pathology resembling that of human FCM, including the presence of misplaced and cytomegalic Rheb CA -expressing neurons that are interchangeably called FCM neurons ( Fig. 1D and E ). These FCM neurons showed a significant increase in soma size and immunoreactivity for phosphorylated protein S6 (phospho-S6), a read-out of mTOR activity, compared to control neurons in mice electroporated with GFP only ( Fig. 1F and G). Mice containing FCM were visually observed to develop convulsive seizures by postnatal day (P) 21.
To better characterize the seizures, we obtained epidural electroencephalography (EEG) recordings combined with video monitoring for 5-7 consecutive days in >2 month-old mice. Mice containing FCM exhibited recurrent, Racine grade 4-5 seizures with classical interictal, tonic, clonic, and postictal periods ( Fig. 1H and I, and movie S1).
Using our mouse model of FCM, we previously reported that FCM neurons display depolarized resting membrane potentials (RMP) compared to their control counterparts and are therefore closer to the threshold for generating action potentials (21) . We thus examined whether silencing FCM neurons without normalizing their morphological abnormalities, which could contribute to seizure generation, would limit the incidence of seizures. To do this, we overexpressed inwardly rectifying potassium channels Kir2.1 that are expected to hyperpolarize neurons expressing these channels as well as decrease their membrane resistances (28) . Using E15 IUE, we co-expressed Kir2.1 with Rheb CA ( Fig. 2A ). In the control condition, GFP was coelectroporated with Rheb CA . Kir2.1 expression in Rheb CA neurons did not prevent the formation of FCM ( Fig. 2A and B) and did not interfere with mTOR hyperactivity as shown by quantification of soma size and phospho-S6 immunofluorescence, respectively ( Fig. 2C ). Furthermore, patch clamp recordings of Rheb CA neurons in acute slices from P21 to P35 validated that Kir2.1 expression did not alter membrane capacitance (a read-out of soma size), but it significantly hyperpolarized Rheb CA neurons and increased their membrane conductance (Fig. 2D ). The properties of current-induced action potentials, including half-width and threshold, were unaltered by Kir2.1 expression ( Fig. 2E and F ), but consistent with the changes in RMP and membrane conductance, larger current injections were required for the generation of action potentials Kir2.1expressing FCM neurons ( Fig. 2G ). This resulted in a significant shift in the input (injected current amplitude)-output (number of action potentials) curve ( Fig. 2H ). Thus, expressing Kir2.1 renders FCM neurons less excitable, in part via hyperpolarizing their RMP further away from the action potential threshold. Importantly, mice overexpressing Kir2.1 in FCM neurons displayed a significant decrease in seizure frequency (from a mean of 4.5 to 0.5 seizures per day) without affecting seizure duration ( Fig. 2I and J). Collectively, these data show that alterations in the electrical properties of FCM neurons are necessary for seizure initiation and that silencing these neurons is sufficient to alleviate seizures.
Aberrant HCN channel expression and increases in cAMP depolarizes FCM neurons
We next examined the electrical properties of FCM neurons using patch clamp recordings in acute brain slices from P26-P42 mice. As we previously reported, we confirmed that FCM neurons displayed significantly depolarized RMPs and increased conductance compared to control neurons in littermate mice expressing only GFP ( Fig. 3A ). Consistent with an increased conductance, there was a significant shift in the input (injected current from their RMP)-output (# of action potentials) curve, suggesting that Rheb CA neurons are less likely to generate action potentials upon depolarizations ( Fig. 3C and D). Using hyperpolarizing current step, one unexpected observation was the present of a robust "sag" response in Rheb CA neurons that was either minimal or mostly not present in control neurons ( Fig. 3E) (29) . Such a sag response suggests the presence of HCN channels. Under control conditions, HCN channels are primarily expressed in deep layer neurons but not in superficial layer (2/3) neurons (29) , which are the neuronal population targeted by IUE at E15. In addition, HCN currents are known to control neuron RMPs and may thus contribute to the depolarized RMP in Rheb CA neurons (17) (18) (19) 30) . We thus preferentially focused on these channels. To validate that these sags were due to the presence of HCN channels, we recorded Rheb CA neurons in the presence of the HCN channel blocker, zatebradine. Zatebradine eliminated the sag response in Rheb CA neurons ( Fig. 3F ). Using voltage-clamp, we applied 500 ms-long hyperpolarizing voltage-steps (from -40 to -130 mV) to activate HCN channels ( Fig. 3G ). Rheb CA neurons displayed large hyperpolarization-activated inward currents that were much larger than in the control neurons ( Fig. 3G and H). These inward currents displayed a slow activation kinetics resembling that of HCN currents requiring a 3 s-long voltage pulse to reach full amplitude ( Supplementary Fig. S1 ) and were significantly reduced in the presence of zatebradine ( Fig. 3G and H). The increased hyperpolarization-induced inward currents were nevertheless not fully blocked by zatebradine presumably due to an increase in the amplitude of inwardly rectifying K currents (Kir) in Rheb CA neurons compared to control due to the cell size increase ( Fig. 3G and H). As evident on the current-membrane potential curves ( Fig. 3H ) and further quantified, zatebradine shifted RMP of cells to hyperpolarized values similar to those of control neurons ( Fig.   3I ). To quantify the h current amplitudes, we measured the amplitude difference (ΔI) between the onset and the end of the current trace using a 500 ms-long voltage step (see dotted line and Ih in Fig. 3G ). Zatebradine significantly reduced these ΔI and there was no residual inward current at -90 mV (Fig. 3J ). Throughout the rest of the manuscript, Ih current amplitude will then be measured as ΔI at -90 mV using this method. Consistent with the normalization of RMP with zatebradine, larger h currents were associated with more depolarized resting membrane potentials in Rheb CA neurons (Fig. 3K ). The amplitude of the h currents was also dependent on the amount of electroporated Rheb CA plasmid and thus mTOR activity level ( Supplementary Fig. S1 ). HCN channels contribute to the generation of rhythmic firing in neurons and heart cells (31-34) and they display different sensitivity to intracellular cAMP levels (17) (18) (19) . We thus examined whether increasing cAMP in Rheb CA neurons would be sufficient to trigger spontaneous, repetitive firing independently of depolarizations. We bath applied a well-characterized cell-permeable adenylate cyclase activator, forskolin, to increase in intracellular cAMP in acute brain slices containing Rheb CA neurons. When recorded at the resting membrane potential, all Rheb CA neurons were depolarized by forskolin and 4/9 neurons generated repetitive action potentials ( Fig. 3L and M).
This effect did not occur in control superficial layer neurons ( Fig. 3L and M), which express very few or no HCN channels. Collectively, these data indicate that Rheb CA neurons express ectopic HCN channels and the abnormal presence of these channels is responsible for the depolarized resting membrane potentials of Rheb CA neurons and their repetitive firing upon increases in intracellular cAMP.
Ectopic HCN4 expression in FCM neurons.
HCN channels are encoded by four genes, HCN1-4, with different expression patterns throughout the brain (17) . In the adult cortex, deep layer pyramidal neurons predominantly express HCN1 and low levels of HCN2 at the protein level (35) . HCN3 and HCN4 display weak, diffuse expression in the cortex (35) . Recently, HCN4 expression has been found in neuronal cell bodies scattered in the cortex that may be GABAergic neurons, but it is nearly absent in the cortex of young adult mice (35) (36) (37) . Furthermore, in situ hybridization and immunoblotting detect low HCN3 and HCN4 mRNA levels in the adult cortex (38) (39) (40) . HCN4 followed by HCN2 channels are the most sensitive to intracellular cAMP levels while HCN1 channels display low sensitivity (17) (18) (19) . We thus immunostained for HCN1-4 in 2 months old mouse brain sections containing FCM. Consistent with previous studies (35) , we identified intense HCN1 staining predominantly in apical dendrites of deep layer neurons and weak, diffuse HCN2 staining in the cortex ( Fig. 4A and B ). However, we found no changes in HCN1 and HCN2 staining pattern in the ipsilateral cortex containing FCM compared to the contralateral cortex as well as no staining in Rheb CA neurons ( Fig. 4E and F ). We found no HCN3 staining in the cortex (data not shown). However, we identified strong HCN4 immunostaining in the cortex containing Rheb CA neurons using two different antibodies against HCN4 ( Fig. 4C and D) . There was no expression of HCN4 in neurons of the contralateral hemisphere suggesting that aberrant HCN channel expression does not result from recurrent seizures. One of the antibodies (Alomone) was previously validated in vivo in conditional knockout mice (36) . In addition, the specificity of both HCN4 antibodies was further confirmed by RNAi followed by immunoblotting in vitro ( Supplementary Fig. S2 ) and exclusive immunoreactivity in neurons electroporated with an HCN4 overexpression plasmid and not in nonelectroporated neurons in the vicinity ( Supplementary Fig. S3 ). About 85% of Rheb CA neurons displayed HCN4 immunoreactivity that decorated their soma, dendrites, and axons ( Fig. 4C , G, and I). Finally, GFP-expressing cells in mice electroporated with GFP instead of Rheb CA did not display HCN4 expression ( Fig. 4H and I) . As a positive control, HCN4 staining was observed in the cerebellum as expected ( Supplementary Fig. S4 ). Thus, Rheb CA -expressing neurons display selective HCN4 expression that was absent in control pyramidal neurons.
HCN4 expression is mTOR-dependent and precedes seizure onset
Higher magnification images illustrate that Rheb CA neurons displaying HCN4 immunoreactivity also expressed increased phospho-S6 staining ( Fig. 5A and B ). To further assess whether increased mTOR activity was responsible for the abnormal expression of HCN4, we treated mice with the mTOR inhibitor rapamycin using the treatment paradigm (1 mg/kg every 48 hours from P1 to 2 months of age) that prevented FCM and the development of seizures (16) . Rapamycin treatment prevented the expression of HCN4 in Rheb CA neurons ( Fig. 5C and D) . Because HCN channel expression has been shown to be up-or down-regulated by seizures (for review see (41)), we examined whether Rheb CA neurons would express HCN during postnatal cortical development prior to the onset of convulsive seizures that were visible in >P21 mice. Recordings in slices from P8-P12 mice showed that Rheb CA neurons displayed zatebradine-sensitive HCN currents that were significantly greater than in control GFP neurons recorded in littermate mice ( Fig. 5E-G ). In addition, there was a significant increase in the HCN currents in Rheb CA neurons during development from P6-12 to P28-P42 but no significant change in control neurons (Fig. 5H) . These data indicate that mTOR hyperactivity drives aberrant expression of HCN4 in FCM neurons prior to the inset of convulsive seizures.
Ectopic HCN4 expression in human TSC and FCDII neurons. Fig. 7D and Supplementary Fig.   S6 for TSC), a pan-neuronal neurofilament (NF) that is accumulated in the soma and dendrites of dysmorphic neurons in human and murine FCD and is considered a marker of these neurons (12, 16, 42, 43) . Dysmorphic SMI 311-immunopositive neurons expressed the neuronal markers, NeuN and neurofilament-light chain (NFL) ( Supplementary Fig. S5 ). Consistent with previous reports, NFL was enriched in the soma of dysmorphic neurons that co-expressed SMI 311 (16) .
We also immunostained for phospho-S6 as a read-out of mTOR activity. SMI 311immunopositive dysmorphic neurons displayed increased immunoreactivity for phospho-S6 compared to normal-appearing, surrounding cells, indicating mTOR hyperactivity ( Supplementary Fig. S5 and S6 ).
In all five tissue samples, we identified HCN4 immunoreactivity (green) in cytomegalic cells and no cellular staining in surrounding cells ( Fig.   6 for FCDII and Fig. 7 for TSC). HCN4-positive fibers were visible in some samples and may correspond to either processes of diseased neurons or thalamic inputs or both (44) . HCN4
immunostaining was performed with the two different antibodies also tested in mice as indicated on the figures. Cytomegalic cells expressing HCN4 displayed enlarged nuclei as shown by hematoxylin staining (in paraffin-embedded samples, Fig. 6A ). In addition, cells displaying HCN4 immunoreactivity expressed increased phospho-S6 ( Fig. 6B and D Blocking HCN4 activity prevents the establishment of epilepsy.
HCN channels contribute to the generation of rhythmic firing in neurons and heart cells (31) (32) (33) (34) .
In addition, data in Figure 3 showed that HCN4 channel expression drove firing in Rheb CA neurons upon cAMP stimulation. To then directly address whether the ectopic expression of HCN4 channels in Rheb CA neurons drives the generation of seizures, we designed a strategy to block HCN channel activity in vivo. We expressed nonfunctional HCN4 (HCN4 NF ) subunits that were generated by adding two mutations into HCN4 (45) . HCN4 NF subunits are expected to form heteromers with endogenous HCN4 subunits and render the endogenous HCN4 channel unable to conduct ions. Indeed, both the sag responses observed in current clamp and the h currents recorded in voltage clamp in Rheb CA neurons were eliminated in Rheb CA neurons that co-expressed HCN4 NF ( Fig. 8A and B ). Furthermore, HCN4 NF expression significantly normalized the resting membrane potentials of Rheb CA neurons (Fig. 8C ) similarly to what was shown with the HCN channel blocker zatebradine in Figure 3 . Similar to the experiments with Kir2.1, expressing HCN4 NF in Rheb CA neurons did not interfere with mTOR hyperactivity as measured by phospho-S6 immunofluorescence and soma size ( Fig. 8D and E ). HCN4 NF expression in Rheb CA neurons did not alter the properties of action potentials (Fig. 8F) or the input-output curve ( Fig. 8G and H) .
Thus, expressing HCN4 NF in Rheb CA neurons did not alter their ability to generate actions potentials, but it hyperpolarized them back to control levels and blocked the activity of endogenous HCN4 channels. Finally, a 7-day long continuous video-EEG monitoring of mice containing Rheb CA neurons expressing HCN4 NF revealed that these mice had no seizures whereas littermate mice containing Rheb CA neurons (without HCN4 NF ) displayed a mean of three daily, convulsive seizures ( Fig. 8I and J) . Together, these data indicate that the ectopic activation of HCN4 channels in FCM neurons are necessary for generating seizures.
Discussion
In light of previous data reporting depolarized RMPs of Rheb CA neurons, we hypothesized that Rheb CA neurons may be more excitable and thus trigger seizures. To test this hypothesis, we expressed Kir2.1 channels in Rheb CA neurons to silence them and examine whether this would limit seizure activity. Kir2.1 expression hyperpolarized the RMPs of Rheb CA neurons and increased their membrane conductance leading to a right shift in the input-output curve without altering their increased cell size, mTOR hyperactivity, and misplacement. These data show that Rheb CA neurons expressing Kir2.1 were indeed less excitable by being hyperpolarized and less responsive to depolarization. As a result of this manipulation, mice had significantly fewer seizures per day, suggesting that Rheb CA neurons are more excitable than control neurons and trigger seizures. We next obtained whole cell patch clamp recordings of Rheb CA neurons to further investigate the mechanism responsible for their increased excitability. We confirmed that Rheb CA neurons have depolarized RMPs and are thus closer to the threshold for generating action potentials. However, they also displayed increased conductance and thus required a larger depolarizing current injection to reach firing threshold, hence Rheb CA neurons were less excitable in response to depolarization than control neurons. These findings initially seemed to contradict the conclusion from the Kir2.1 experiment that Rheb CA neurons could trigger seizures. However, we further identified the aberrant expression of HCN currents that provided an explanation for the unusual, increased likelihood of Rheb CA neurons to generate action potentials independent of depolarizing inputs as detailed below. In young adults, Rheb CA neurons expressed larger inward currents than in controls, including a combination of HCN-and presumed Kir-mediated currents.
Outward currents could not be examined in Rheb CA neurons due to poor space clamp leading to unclamped firing upon depolarizing voltage pulses. Due to the large increase in Rheb CA neuron size, it was not surprising to find larger Kir-mediated currents, which are well-known to be expressed in control layer 2/3 pyramidal neurons as G protein inwardly rectifying K channels (46, 47) . However, finding HCN-mediated currents was surprising because control layer 2/3 pyramidal neurons are not known to express such currents, as confirmed here. HCN channels, in particular HCN2 and HCN4, are sensitive to cAMP levels with higher cAMP levels leading to increased HCN-mediated currents (17) (18) (19) . Considering that the levels of cAMP increases in developing hippocampal neurons (doubled from P6 to P15) (48) and could be altered in disease condition, it is conceivable that the increase in HCN currents could also be due to increased cAMP levels in Rheb CA neurons compared to control neurons. We could not directly measure cAMP levels in Rheb CA neurons. However, using immunostaining we identified the selective HCN4 expression that was not present in control neurons andexpressing HCN4 NF led to a significant reduction of HCN-mediated current. These data suggest that HCN-mediated currents in Rheb CA neurons are primarily due to the ectopic expression of HCN4 channels independent of changes in cAMP levels.
With respect to neuron excitability, we found that increasing intracellular cAMP levels with forskolin was sufficient to trigger the firing of Rheb CA neurons. Therefore, although Rheb CA neurons have an increased membrane conductance and require more current injection to reach firing threshold, they are more depolarized and an increase in intracellular cAMP levels, as opposed to excitatory input-induced depolarization, acts as the trigger to induce Rheb CA neuron firing. These data show an unanticipated and novel mechanism of excitability that is consistent with a significant decrease in the excitatory drive (i.e., frequency of spontaneous excitatory synaptic inputs) onto Rheb CA neurons (21) . Identifying a cAMP-dependent excitability in Rheb CA neurons is tantalizing because cortical pyramidal neurons receive multiple inputs that activate receptors leading to cAMP increases. These inputs include noradrenergic and dopaminergic innervation from the locus coeruleus (e.g., (49, 50) ) and the ventral tegmental area (e.g., Gscoupled β1-and β2-adrenergic receptors and D1 and D5 receptors, see (47, 51) for references).
Noradrenaline or dopamine released from these inputs would thus contribute to cAMP increases and HCN4 channel activation that could lead to firing and seizures It is also conceivable that inhibitors of these receptors, preventing increases in intracellular cAMP levels, may alleviate seizure activity.
Regarding the identity of the HCN channels expressed in Rheb CA neurons, we found the selective expression of HCN4 channels by immunostaining. It is possible that Rheb CA neurons also acquire HCN1 or HCN2 channels at densities below detection levels for immunostaining.
Nevertheless, the important finding was the fact that HCN4 expression was absent in control pyramidal neurons in our sections and has not been reported in cortical pyramidal neurons in young adult mice despite the presence of mRNA neurons (35) (36) (37) (38) (39) (40) . We found that about 85% of the Rheb CA neurons labeled with tdTomato displayed HCN4 immunoreactivity. Using co-electroporation of two plasmids, we routinely achieved colocalization of the two plasmids in 92% of the electroporated cells (52) . As such we underestimate the percent of cells expressing HCN4 by 8% leading to an adjusted total of about 93% of the cells expressing HCN4. Considering that every recorded Rheb CA neuron expressed HCN-mediated currents, albeit with different amplitude, it is possible that HCN4 expression in a subset of Rheb CA neurons was below the detection limit for immunostaining. Finding HCN4 channels in neurons that normally do not express these channels may seem surprising. However, as shown in the developing hippocampus (48, 53) , HCN4 is strongly expressed perinatally in the cortex and is dramatically decreased in young adults (P30) (37) . HCN4 channels are thus intrinsic to cortical neurons during development. Considering HCN4 expression was mTOR-dependent, and mTOR increases protein translation, it is conceivable that the ectopic HCN4 expression results from increased translation of mRNA already present in pyramidal cortical neurons.
Our findings add to a large body of literature on HCN expression and seizures. Indeed, several studies have reported alterations in the expression of HCN, in particular, HCN1 and HCN2, in different types of epilepsy in both mice and humans (for review (41, 54) ). One recent study reported that blocking HCN1 channel activity prevented absence seizures (55) , suggesting that an increase in HCN1 channel expression contributes to the generation of absence seizures. Another study reported no change in HCN4 expression in the hippocampus following febrile seizures despite changes in HCN1 (56) . Loss-of-function mutations in HCN4 has also recently been associated with benign myoclonic epilepsy (57) . More recently, increased HCN4 expression in the hippocampal dentate gyrus has been reported in individuals with SUDEP (58). However, it was unclear whether the alterations in increased HCN4 expression preceded seizure occurrence and were responsible for seizures. Our model of FCD-associated seizures allowed us to demonstrate that HCN4 expression is uniquely expressed in dysmorphic neurons and precedes seizures. Indeed, patch clamp recordings reported the abnormal expression of HCN currents in Rheb CA neurons as early as P8, about two weeks prior to the onset of convulsive seizures (observed starting at P21).
In addition, no HCN4 expression was detected in the contralateral hemispheres lacking FCM, but experiencing epileptiform activity. Finally, we show clear causality between HCN4 activity and seizure occurrence, as genetically blocking HCN4 activity prevented the development of seizures.
Identifying ectopic HCN4 has several important clinical implications. At the present time, there are no HCN blockers that are selective for HCN4. However, our findings support HCN4 as a prime candidate for shRNA-based gene therapy for treating seizures associated with FCDII and TSC that exhibit focal cortical malformations. While ectopic HCN4 expression was eliminated with rapamycin treatment, directly targeting HCN4 for epilepsy treatment would prevent the severe adverse events that occur when using the higher rapamycin doses necessary to improve efficacy (7) . Furthermore, considering that HCN4 is downstream of mTOR signaling, our findings are likely applicable to other mTORopathies resulting from mutations in the mTOR and GATOR pathway genes (e.g., AKT, PI3K, mTOR, RHEB, DEPDC5, NRPL2/3 (3, 4, (59) (60) (61) (62) (63) (64) (65) (66) (67) (68) (69) (70) (71) .
In conclusion, we have provided evidence that enlarged, dysmorphic mutant neurons in mouse and human FCMs express HCN4 channels that are normally absent in cortical neurons in young adults. This ectopic HCN4 channel expression is mTOR-dependent, precedes the development of epilepsy, and contributes to the generation of seizures by enhancing the excitability of FCM neurons. Our findings add to the body of literature on HCN channels in epilepsy, and more importantly, highlight a novel mechanism of seizures by the unexpected contribution of the isoform 4 of HCN channels that has high cAMP-sensitivity. This mechanism can explain how sensory stimulations leading to the activation of specific cAMP-generating dopaminergic or adrenergic inputs onto FCM neurons would trigger seizures. In addition, the unique expression of HCN4 channels in dysmorphic FCM neurons provides a highly specific target for gene therapy for epilepsy treatment for individuals with TSC and FCDII.
Materials and Methods
Animals
Research protocols were approved by the Yale University Institutional Animal Care and Use Committee. All experiments were performed on CD-1 (Charles River), an outbred strain of mice of either sex.
In utero electroporation and plasmids
Each DNA plasmid (Supplementary Table 2 
Brain slice preparation and Immunohistochemistry
Mice were deeply anesthetized with pentobarbital (50 mg/kg) and perfused transcardially with ice cold phosphate buffered saline (PBS, pH 7.4) followed by ice cold paraformaldehyde (PFA, 4%).
Perfused brains were also drop fixed in 4% PFA for an additional hour after removal from the skull. Fixed brains were cryoprotected with 30% sucrose in PBS overnight at 4°C and serially sectioned into 50 μm thick sections using a freezing microtome. Sections were blocked for 1 hour at room temperature in blocking buffer consisting of 2% BSA and 0.3% Triton X-100 in PBS.
Floating sections were incubated overnight at 4ºC in primary antibodies diluted in blocking buffer. The list of antibodies is detailed in Supplementary Table 3 . Antibodies were extensively used and validated by previous studies. In addition, the specificity of the HCN4 antibody was further confirmed by RNAi in vitro ( Supplementary Fig. S2 ) and exclusive immunoreactivity in neurons electroporated with an HCN4 overexpression plasmid and not in non-electroporated neurons in the vicinity ( Supplementary Fig. S3 ).
Acute slice preparation and whole cell recording. The resting membrane potential was recorded within the first 10 seconds after achieving wholecell configuration in current-clamp mode, while the cell is at rest without any holding current. The membrane conductance was calculated using the average membrane potential change from ten hyperpolarizing current injections of -500 pA in current-clamp mode when the cell is at rest. The action potential half width was calculated at half of the peak amplitude of a single action potential induced by current injection. The action potential firing threshold was defined as the membrane potential at which the first derivative of an action potential in current-clamp mode achieves 10% of its peak velocity (dV/dt). The action potential input-output curve was generated by injecting positive current in current-clamp mode from 0 to 1.4 or 2 nA at 50 or 100 pA increments for 500 msec.
Human tissue sample
Human tissue was obtained from different sources: directly from the surgery room or from the Tuberous sclerosis Alliance. Freshly resected tissue was rapidly frozen in 2-Methylbutane (isopentane; Acros Organics MS; AC12647-0010) at <-80ºC, rapidly frozen in liquid nitrogen and then stored at -80ºC (for immunoblotting and immunostaining), or fixed in 10% formalin (for immunohistochemistry Supplementary Table S3 ) overnight. HRP-conjugated anti-rabbit or antimouse were used as secondary antibodies.
Statistical analyses
All analyses were conducted blindly knowing only the arbitrarily assigned animal ID (independent of electroporation condition). Statistical tests and plots were performed using Prism 7 (GraphPad Software, Inc.), with P < 0.05 for significance for all experiments. Specific statistical tests used for each experiment are described in Supplementary Table 4 . Data are presented as mean ± SEM. Movie S1: Example of a convulsive seizure in a mouse containing a FCM 
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